TEAS Plus New Application

DURTIMA

Glaxo Group Limited

Trademark/Service Mark Application, Principal Register

PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

TEAS Plus Application

Serial Number: 97477700
Filing Date: 06/27/2022

NOTE: Data fields with the * are mandatory under TEAS Plus. The wording "(if applicable)" appears where the field is only mandatory under the facts of the particular application.


The table below presents the data as entered.

Input Field
Entered
TEAS Plus YES
MARK INFORMATION
*MARK DURTIMA
*STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT DURTIMA
*MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Glaxo Group Limited
*MAILING ADDRESS 980 Great West Road
*CITY Brentford, Middlesex
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY England
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
TW89GS
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
*TYPE private company limited by shares (prc)
* STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY WHERE LEGALLY ORGANIZED United Kingdom
GOODS AND/OR SERVICES AND BASIS INFORMATION
*INTERNATIONAL CLASS 005 
*IDENTIFICATION Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
*FILING BASIS SECTION 44(e)
       *FOREIGN REGISTRATION
       COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United Kingdom
       *FOREIGN REGISTRATION
       NUMBER
2389779
       *FOREIGN REGISTRATION
       DATE
04/19/2005
       FOREIGN REGISTRATION
       EXPIRATION DATE
04/19/2025
       DATE FOREIGN REGISTRATION
       RENEWED
        (if applicable)
11/19/2014
       FOREIGN REGISTRATION FILE NAME(S)
       ORIGINAL PDF FILE reg-15251481-150727951_._ DURTIMA_REN_CERT.pdf
       CONVERTED PDF FILE(S)
       (1 page)
\\TICRS\EXPORT18\IMAGEOUT 18\974\777\97477700\xml1\ FTK0003.JPG
       ORIGINAL PDF FILE reg-15251481-150727951_._ DURTIMA_REG_CERT.pdf
       CONVERTED PDF FILE(S)
       (1 page)
\\TICRS\EXPORT18\IMAGEOUT 18\974\777\97477700\xml1\ FTK0004.JPG
        STANDARD CHARACTERS
       OR EQUIVALENT
YES
ADDITIONAL STATEMENTS SECTION
*TRANSLATION
(if applicable)
 
*TRANSLITERATION
(if applicable)
 
*CLAIMED PRIOR REGISTRATION
(if applicable)
The applicant claims ownership of active prior U.S. Registration Number(s) 4986098. 
*CONSENT (NAME/LIKENESS)
(if applicable)
*CONCURRENT USE CLAIM
(if applicable)
 
ATTORNEY INFORMATION
NAME Elizabeth Rucki
ATTORNEY DOCKET NUMBER 84190299
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME GSK
INTERNAL ADDRESS 5.5A, LBP
STREET 5 Moore Drive
CITY Research Triangle Park
STATE North Carolina
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 27709
PHONE 919-353-8081
FAX 919-315-3023
EMAIL ADDRESS trademarks@gsk.com
OTHER APPOINTED ATTORNEY Christopher M. Hanes
CORRESPONDENCE INFORMATION
NAME Elizabeth Rucki
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE trademarks@gsk.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) NOT PROVIDED
FEE INFORMATION
APPLICATION FILING OPTION TEAS Plus
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 250
*TOTAL FEES DUE 250
*TOTAL FEES PAID 250
SIGNATURE INFORMATION
* SIGNATURE /Elizabeth K. Rucki/
* SIGNATORY'S NAME Elizabeth K. Rucki
* SIGNATORY'S POSITION Attorney of record, TX bar member
SIGNATORY'S PHONE NUMBER 919-353-8081
* DATE SIGNED 06/24/2022
SIGNATURE METHOD Sent to third party for signature



PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


Trademark/Service Mark Application, Principal Register

TEAS Plus Application

Serial Number: 97477700
Filing Date: 06/27/2022

To the Commissioner for Trademarks:

MARK: DURTIMA (Standard Characters, see mark)
The literal element of the mark consists of DURTIMA. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Glaxo Group Limited, a private company limited by shares (prc) legally organized under the laws of United Kingdom, having an address of
      980 Great West Road
      Brentford, Middlesex TW89GS
      England
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

For specific filing basis information for each item, you must view the display within the Input Table.
International Class 005:  Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
Based on Foreign Registration: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services, and submits a copy of United Kingdom registration number 2389779, and/or proof of renewal, registered 04/19/2005 with a renewal date of 11/19/2014 and an expiration date of 04/19/2025, and translation thereof, if appropriate.

Original PDF file:
reg-15251481-150727951_._ DURTIMA_REN_CERT.pdf
Converted PDF file(s) (1 page)
Foreign Registration-1
Original PDF file:
reg-15251481-150727951_._ DURTIMA_REG_CERT.pdf
Converted PDF file(s) (1 page)
Foreign Registration-1

The foreign registration that is the basis of the U.S. application under §44(e) of the Trademark Act includes a claim of standard characters or the country of origin's standard character equivalent.


Claim of Active Prior Registration(s)
The applicant claims ownership of active prior U.S. Registration Number(s) 4986098.


The owner's/holder's proposed attorney information: Elizabeth Rucki. Other appointed attorneys are Christopher M. Hanes. Elizabeth Rucki of GSK, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      5.5A, LBP
      5 Moore Drive
      Research Triangle Park, North Carolina 27709
      United States
      919-353-8081(phone)
      919-315-3023(fax)
      trademarks@gsk.com
The docket/reference number is 84190299.
Elizabeth Rucki submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.

The applicant's current Correspondence Information:
      Elizabeth Rucki
       PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@gsk.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $250 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /Elizabeth K. Rucki/   Date: 06/24/2022
Signatory's Name: Elizabeth K. Rucki
Signatory's Position: Attorney of record, TX bar member
Signatory's Phone Number: 919-353-8081
Signature method: Sent to third party for signature
Payment Sale Number: 97477700
Payment Accounting Date: 06/27/2022

Serial Number: 97477700
Internet Transmission Date: Mon Jun 27 16:55:29 ET 2022
TEAS Stamp: USPTO/FTK-XXX.XX.XX.X-202206271655298148
20-97477700-8201d48fc6785c36ec6ea9767b75
b1a935f7f426056a69be63e145f56e017ce91-DA
-55294641-20220623150727951721

TEAS Plus New Application [image/jpeg]

TEAS Plus New Application [image/jpeg]

TEAS Plus New Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed